These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37183797)

  • 41. [Association between bone turnover markers, bone mineral density and vitamin D in Moroccan postmenopausal women].
    Elmaataoui A; Elmachtani Idrissi S; Dami A; Bouhsain S; Chabraoui L; Ouzzif Z
    Pathol Biol (Paris); 2014 Feb; 62(1):49-54. PubMed ID: 24461391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
    J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients.
    Cianciolo G; Tondolo F; Barbuto S; Iacovella F; Zavatta G; Altieri P; Grandinetti V; Comai G; Cozzolino M; La Manna G
    Am J Nephrol; 2021; 52(8):611-619. PubMed ID: 34518468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: A Hospital-based cross-sectional study.
    Etta PK; Sharma RK; Gupta A
    Saudi J Kidney Dis Transpl; 2017; 28(4):874-885. PubMed ID: 28748891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.
    Liu Y; He Q
    Clin Lab; 2015; 61(7):839-43. PubMed ID: 26299086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of vitamin D, bone mineral density and parathyroid hormone levels in adults with low bone density.
    Kota S; Jammula S; Kota S; Meher L; Modi K
    Indian J Orthop; 2013 Jul; 47(4):402-7. PubMed ID: 23960286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones.
    Abe Y; Ejima E; Fujiyama K; Kiriyama T; Ide A; Sera N; Tominaga T; Ashizawa K; Yokoyama N; Eguchi K
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):203-9. PubMed ID: 10671948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.
    Cruz DN; Wysolmerski JJ; Brickel HM; Gundberg CG; Simpson CA; Mitnick MA; Kliger AS; Lorber MI; Basadonna GP; Friedman AL; Insogna KL; Bia MJ
    Transplantation; 2001 Jul; 72(1):83-8. PubMed ID: 11468539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mineral bone disorder and osteoporosis in hemodialysis patients.
    Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
    Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of bone loss after cardiac transplantation.
    Guo CY; Johnson A; Locke TJ; Eastell R
    Bone; 1998 Mar; 22(3):267-71. PubMed ID: 9514219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
    Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Circulating bone turnover markers and their relationships in hemodialysis patients with vitamin D deficiency].
    Kulicki P; Żebrowski P; Sokalski A; Klatko W; Birecka M; Mieczkowski M; Niemczyk S; Małyszko J; Matuszkiewicz-Rowińska J
    Wiad Lek; 2019; 72(11 cz 2):2202-2209. PubMed ID: 31860837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus.
    Zhao C; Liu G; Zhang Y; Xu G; Yi X; Liang J; Yang Y; Liang J; Ma C; Ye Y; Yu M; Qu X
    J Clin Lab Anal; 2020 Apr; 34(4):e23112. PubMed ID: 31733013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of follicle-stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition.
    Li L; Pi YZ; Zhang H; Dai RC; Yuan LQ; Sheng ZF; Wu XY
    J Clin Lab Anal; 2023 May; 37(9-10):e24899. PubMed ID: 37272770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.